MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Work continues on a new injectable, sustained-release technology that Rainbow Coral Corp. (OTCBB: RBCC) hopes can help prevent a deadly epidemic of prescription narcotic overdoses. In a statement to the press reported by Benzinga earlier this month, National Institute on Drug Abuse (NIDA) Director Nora Volkow said that opioid-receptor blocker Naltrexone can improve lives and reduce risks of overdose. Volkow called such medication-assisted therapies “markedly underutilized.”
Help employers find you! Check out all the jobs and post your resume.